BioSphere Medical, which has an FDA approved method to treat symptomatic uterine fibroids using microsphere technology, has signed an agreement with DuPont Applied BioSciences to evaluate potential peripheral vascular and embolotherapy research, development, and manufacturing projects.
The agreement establishes a “non-binding framework” for the parties to consider and evaluate potential projects that target and deliver leading edge solutions in embolotherapy.
full article >> http://www.onemedplace.com/blog/archives/500
Saturday, December 22, 2007
Biosphere-DuPont Collaboration May Create Higher-Margin Microspheres
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment